Last reviewed · How we verify
NCT04258891: DYNAKT
Multidimensional System to Dynamically Predict Graft Survival After Kidney Transplantation
trial testing No intervention in Kidney Transplant Failure in 14,000 participants. Completed in 30 June 2020.
31 December 2019
Quick facts
| Lead sponsor | Paris Translational Research Center for Organ Transplantation |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 14,000 |
| Start date | 1 January 2004 |
| Primary completion | 31 December 2019 |
| Estimated completion | 30 June 2020 |
| Sites | 18 locations across France, Chile, Argentina, Spain, Croatia, United States, Brazil |
Drugs / interventions tested
- No intervention
Conditions studied
- Kidney Transplant Failure — all drugs for Kidney Transplant Failure →
Sponsor
Paris Translational Research Center for Organ Transplantation — full company profile →
Who can join
18 and older, any sex, with Kidney Transplant Failure. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The incidence of end stage renal disease (ESRD) is rapidly increasing, now affecting an estimated 7.4 million people worldwide. Numerous parameters such as demographic, clinical and functional factors drive the deterioration of the kidney, ultimately leading to ESRD. Although some ESRD prediction models have been derived in the past years, none of these models are dynamic: they do not integrate the repeated measurements recorded throughout individuals' follow-up. As highlighted in several studies, kidney function repeated measurements (i.e., trajectories) are highly associated with graft survival after kidney transplantation. The investigators made the hypothesis that these trajectories may bring relevant information in the context of graft survival risk prediction model. Hence, combining these trajectories with standard graft survival risk factors may enhance prediction performance. This could permit to derive a robust tool that could be updated over time by continuously capturing patient' personal evolution.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Dynamic prediction of renal survival among deeply phenotyped kidney transplant recipients using artificial intelligence: an observational, international, multicohort study.
Raynaud M, Aubert O, Divard G, Reese PP, et al · · 2021 · cited 51× · PMID 34756569 · DOI 10.1016/s2589-7500(21)00209-0 -
Dynamic prediction of renal survival using artificial intelligence: an international study of deeply phenotyped cohorts of kidney transplant recipients
Loupy A, Raynaud M, Aubert O, Reese PP, et al · · 2020 · DOI 10.21203/rs.3.rs-85478/v1
Verify or expand the search:
- PubMed search for NCT04258891
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of No intervention
Trials testing the same drug.
- NCT06643052 — Cahnge in Management of Suspected Early Onset Neonetal Sepsis After Assimilation of Early Onset Sepsis Calculator · not yet recruiting
- NCT07540611 — Gonadotropin Therapy in Idiopathic Hypogonadal Non-Obstructive · NA · not yet recruiting
- NCT07291778 — Doppler Evaluation for Congestive Acute Kidney Injury in Critical Illness · NA · not yet recruiting
- NCT07490431 — An Observational Study to Learn More About How Elinzanetant is Used and How Well it Works for Women With Menopause Sympt · not yet recruiting
- NCT07515365 — Colitis Patterns in Patients With Lower GI Symptoms · not yet recruiting
Other recruiting trials for Kidney Transplant Failure
Currently open trials in the same condition.
- NCT06186843 — Plant-based Diet for Kidney Transplant Recipients · NA · active not recruiting
- NCT05897047 — The smartNTx Trial: A Prospective, Randomized Controlled Trial (RCT) to Investigate Additional Interventional Telemedica · NA · active not recruiting
- NCT06505200 — Observational Cohort Study Renal Transplantation University Hospitals Leuven · active not recruiting
Other Paris Translational Research Center for Organ Transplantation trials
Trials by the same sponsor.
- NCT07532382 — Personalized Stories for Pediatric Kidney Recipients · recruiting
- NCT07091214 — Molecular Transcriptomics in Diagnosing Pediatric Kidney Transplant Rejection: the PANDA-Kids-ATLAS Study · not yet recruiting
- NCT07269275 — HLA Eplet Mismatches to Predict Long-term Kidney Transplant Outcomes · completed
- NCT06496269 — Impact of Microvascular Inflammation on Kidney Allograft Outcome · completed
- NCT06436586 — Impact of HLA Evolutionary Divergence and HLA Donor-recipient Molecular Mismatches on Kidney Allograft Rejection · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04258891 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Paris Translational Research Center for Organ Transplantation
- Last refreshed: 16 September 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04258891.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing